Colorectal Cancer Statistics From the Veterans Affairs Central Cancer Registry
- PMID: 27301717
- PMCID: PMC5099105
- DOI: 10.1016/j.clcc.2016.04.005
Colorectal Cancer Statistics From the Veterans Affairs Central Cancer Registry
Abstract
Background: Colorectal cancer (CRC) is a common and potentially deadly disease. Although the United States has robust cancer data reporting, information from the Department of Veterans Affairs (VA) healthcare system has often been underrepresented in national cancer data sources. We describe veterans with incident CRC in terms of their patient and tumor characteristics and mortality.
Patients and methods: Patients diagnosed or treated with CRC at any VA institution in the fiscal years 2009 to 2012 were identified using 3 data sources: (1) VA Central Cancer Registry (VACCR); (2) VA Corporate Data Warehouse; and (3) VA Reports and Measures Portal. The CRC frequencies within the VA population and survival curves were examined descriptively and compared with the national projections using Surveillance, Epidemiology, and End Results program data.
Results: A total of 12,551 veterans with CRC were included in the present analysis. The median age at diagnosis was 65.5 years. Approximately 97% (n = 12,229) of the CRC cases were diagnosed among men. Approximately 44% (n = 5517) of the patients were diagnosed with localized disease. The 3-year survival rate was associated with age (P < .01) and stage (P < .01) at diagnosis. We identified a possible decrease in VA CRC incidence over time.
Conclusion: Although the VA CRC patient population was heavily skewed toward the male gender, the patient and tumor characteristics were similar between the incident CRC cases reported by the VACCR and those reported to the Surveillance, Epidemiology, and End Results program. This suggests that research findings resulting from the VACCR might have applicability beyond the VA healthcare system setting.
Keywords: Colorectal; Incidence; Mortality; Neoplasms; U.S. Department of Veterans Affairs.
Published by Elsevier Inc.
Conflict of interest statement
The authors report no conflicts of interest in this work. Dr. Zullig is support by a Veterans Affairs Health Services Research & Development Career Development Award (CDA 13-025). Drs. Bosworth (RCS 08-027) and Weinberger (RCS 91-408) are supported by Senior Research Career Scientist awards from VA Health Services Research & Development. This content is solely the responsibility of the authors and does not reflect the position or policy of the U.S. Department of Veterans Affairs of the United States Government.
Figures




Similar articles
-
Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System: 2010 Update.Mil Med. 2017 Jul;182(7):e1883-e1891. doi: 10.7205/MILMED-D-16-00371. Mil Med. 2017. PMID: 28810986 Free PMC article.
-
Cancer incidence among patients of the U.S. Veterans Affairs Health Care System.Mil Med. 2012 Jun;177(6):693-701. doi: 10.7205/milmed-d-11-00434. Mil Med. 2012. PMID: 22730846 Free PMC article.
-
Colonoscopy and colorectal cancer rates among octogenarians and nonagenarians: nationwide study of US veterans.Clin Interv Aging. 2019 Mar 26;14:609-614. doi: 10.2147/CIA.S192497. eCollection 2019. Clin Interv Aging. 2019. PMID: 30988602 Free PMC article.
-
The Veterans Affairs Rheumatoid Arthritis Registry: A unique population in rheumatoid arthritis research.Semin Arthritis Rheum. 2025 Feb;70S:152580. doi: 10.1016/j.semarthrit.2024.152580. Epub 2024 Nov 9. Semin Arthritis Rheum. 2025. PMID: 39580339 Review.
-
Hypofractionation Radiation Therapy for Definitive Treatment of Selected Cancers: A Systematic Review.Washington (DC): Department of Veterans Affairs (US); 2023 May. Washington (DC): Department of Veterans Affairs (US); 2023 May. PMID: 37769054 Free Books & Documents. Review.
Cited by
-
Cardiovascular disease-related chronic conditions among Veterans Affairs nonmetastatic colorectal cancer survivors: a matched case-control analysis.Cancer Manag Res. 2019 Jul 22;11:6793-6802. doi: 10.2147/CMAR.S191040. eCollection 2019. Cancer Manag Res. 2019. PMID: 31413631 Free PMC article.
-
Aryl hydrocarbon receptor nuclear translocator limits the recruitment and function of regulatory neutrophils against colorectal cancer by regulating the gut microbiota.J Exp Clin Cancer Res. 2023 Mar 1;42(1):53. doi: 10.1186/s13046-023-02627-y. J Exp Clin Cancer Res. 2023. PMID: 36859266 Free PMC article.
-
Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon Cancer.Biomed Res Int. 2020 Mar 30;2020:6107865. doi: 10.1155/2020/6107865. eCollection 2020. Biomed Res Int. 2020. PMID: 32337262 Free PMC article.
-
Colorectal neoplasia differentially expressed: a long noncoding RNA with an imperative role in cancer.Onco Targets Ther. 2018 Jun 29;11:3755-3763. doi: 10.2147/OTT.S162754. eCollection 2018. Onco Targets Ther. 2018. PMID: 29988699 Free PMC article. Review.
-
Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53.Med Sci Monit. 2017 Feb 20;23:919-928. doi: 10.12659/msm.903462. Med Sci Monit. 2017. PMID: 28216611 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: a cancer journal for clinicians. 2015;65(1):5–29. - PubMed
-
- Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA: a cancer journal for clinicians. 2014;64(2):104–117. - PubMed
-
- [Accessed December 20, 2015];Department of Veterans Affairs Veteras Health Administration Directive 1072: Release of VA Data to State Cancer Registries. 2014 Available from: http://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=3028.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical